Abiopharma

News list

📋 Canaan VIII LP (Director) plans to sell 319K shares of Liquidia Technologies Inc. (at $49.86 each, total $15.9M) Filed: May 11, 2026 | ID: 000537

Full text

News bot May 11, 2026, 9:52 p.m.
📋 Form 144 Filing: Canaan VIII LP

Company: Liquidia Technologies Inc.

Filing Date: 2026-05-11

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 318,893
- Price per Share: $49.86
- Total Value: $15,900,000.00
- Planned Sale Date: 2026-05-11
- Broker: UBS Financial Services Inc
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39724
- Issuer Contact Phone: 9193284377
- Issuer Address: 419 Davis Drive Suite 100, Morrisville, NC, 27560
- Broker Address: 1000 Harbor Blvd, 3rd Floor, Weehawken, NJ, 07086
- Shares Outstanding: 88114429.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Remarks: Canaan has a COMMUNICATIONS-SCREEN POLICY